Published in Cancer Imaging on January 25, 2012
Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. J Oncol Pract (2013) 0.93
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic. Alzheimers Dement (2016) 0.80
A blood screening test for Alzheimer's disease. Alzheimers Dement (Amst) (2016) 0.77
Introduction to special issue on Advances in blood-based biomarkers of Alzheimer's disease. Alzheimers Dement (Amst) (2016) 0.76
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med (2005) 14.47
Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med (2009) 11.96
MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med (2007) 10.28
Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology (2004) 5.37
Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet (2010) 4.79
Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol (2009) 4.13
Rising use of diagnostic medical imaging in a large integrated health system. Health Aff (Millwood) (2008) 4.05
Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol (2008) 3.92
Dedicated breast CT: initial clinical experience. Radiology (2008) 3.70
Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol (2008) 3.06
Positron emission tomography for in-vivo measurement of regional blood flow, oxygen utilisation, and blood volume in patients with breast carcinoma. Lancet (1984) 3.05
Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients with cancer: initial results from the National Oncologic PET Registry. J Clin Oncol (2008) 2.96
Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg (2009) 2.79
Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA (2010) 2.68
Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med (2003) 2.20
Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J Clin Oncol (2011) 2.17
Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess (2007) 2.10
Experience with mammography in a tumor institution. Evaluation of 1,000 studies. Radiology (1960) 2.06
Role of positron-emission tomography scan in the diagnosis and management of breast cancer. Oncology (Williston Park) (2009) 2.03
Breast magnetic resonance imaging for preoperative locoregional staging. Am J Surg (2008) 2.01
Mammography in 53,803 women from the New Hampshire mammography network. Radiology (2000) 1.96
Effect of computerized order entry with integrated decision support on the growth of outpatient procedure volumes: seven-year time series analysis. Radiology (2009) 1.90
Early detection of breast cancer: benefits and risks of supplemental breast ultrasound in asymptomatic women with mammographically dense breast tissue. A systematic review. BMC Cancer (2009) 1.89
Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology (1991) 1.80
Physician orders contribute to high-tech imaging slowdown. Health Aff (Millwood) (2010) 1.79
AHRQ series paper 3: identifying, selecting, and refining topics for comparative effectiveness systematic reviews: AHRQ and the effective health-care program. J Clin Epidemiol (2009) 1.73
Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst (2002) 1.70
Review of preoperative magnetic resonance imaging (MRI) in breast cancer: should MRI be performed on all women with newly diagnosed, early stage breast cancer? CA Cancer J Clin (2009) 1.68
PET/CT today and tomorrow. J Nucl Med (2004) 1.68
Expanded use of imaging technology and the challenge of measuring value. Health Aff (Millwood) (2008) 1.66
Value of mammography in reduction of mortality from breast cancer in mass screening. Am J Roentgenol Radium Ther Nucl Med (1973) 1.65
Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med (2003) 1.64
Use of high-frequency ultrasonic waves for detecting changes of texture in living tissues. Lancet (1951) 1.61
Breast CT. Annu Rev Biomed Eng (2007) 1.50
Diffusion of computer-aided mammography after mandated Medicare coverage. Arch Intern Med (2010) 1.50
Prospective multicenter study of axillary nodal staging by positron emission tomography in breast cancer: a report of the staging breast cancer with PET Study Group. J Clin Oncol (2004) 1.45
Indications for breast MRI in the patient with newly diagnosed breast cancer. J Natl Compr Canc Netw (2009) 1.40
Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast. Radiology (2010) 1.33
Nuclear magnetic resonance as a new tool in cancer research: human tumors by NMR. Ann N Y Acad Sci (1973) 1.29
NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in cancer. J Natl Compr Canc Netw (2007) 1.26
The ultrasonic visualization of carcinoma of the breast and other soft-tissue structures. Cancer (1954) 1.21
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: the MONET - randomised controlled trial. Eur J Cancer (2010) 1.19
Breast sonography. AJR Am J Roentgenol (1991) 1.17
Human breast cancer in vivo: H-1 and P-31 MR spectroscopy at 1.5 T. Radiology (1988) 1.17
Computed tomographic evaluation of the breast. AJR Am J Roentgenol (1978) 1.17
The accuracy of "one-stop" diagnosis for 1,110 patients presenting to a symptomatic breast clinic. J R Coll Surg Edinb (1999) 1.11
Pre-operative staging of breast cancer with breast MRI: one step forward, two steps back? Breast (2007) 1.10
Special report: exome sequencing for clinical diagnosis of patients with suspected genetic disorders. Technol Eval Cent Assess Program Exec Summ (2013) 1.07
Monte Carlo and phantom study of the radiation dose to the body from dedicated CT of the breast. Radiology (2008) 1.06
1999 ICP Distinguished Scientist Award. The history of positron emission tomography. Mol Imaging Biol (2002) 1.02
More mastectomies: is this what patients really want? J Clin Oncol (2009) 1.00
MR imaging of the breast using gadolinium-DTPA. J Comput Assist Tomogr (1986) 1.00
Pre-operative MRI for women with newly diagnosed breast cancer: perspectives on clinician and patient decision-making when evidence is uncertain. Breast (2010) 0.95
Digital mammography. ROC studies of the effects of pixel size and unsharp-mask filtering on the detection of subtle microcalcifications. Invest Radiol (1987) 0.95
Sensitivity, specificity and predictive values of breast imaging in the detection of cancer. Br J Cancer (1997) 0.93
Diagnostic value of radiological breast imaging in a non-screening population. Int J Cancer (2001) 0.91
Digital mammography: performance considerations and current detector designs. Acad Radiol (1996) 0.90
The impact of breast MRI on surgical decision-making: are patients at risk for mastectomy? J Surg Oncol (2009) 0.88
Dynamic helical CT mammography of breast cancer. Radiat Med (2006) 0.86
Comparative effectiveness research: what it means for radiology. Radiology (2009) 0.86
The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy. Diagn Interv Radiol (2007) 0.86
Current applications and future prospects of fine-needle aspiration biopsy of locoregional lymph nodes in the management of breast cancer. Cancer (2009) 0.86
Dynamic helical CT of breast tumors. J Comput Assist Tomogr (1998) 0.83
Ultrasonographic posttreatment follow-up of breast cancer patients. J Ultrasound Med (1991) 0.82
Assessing the comparative effectiveness of a diagnostic technology: CT colonography. Health Aff (Millwood) (2008) 0.82
Current uses of ultrasound in the evaluation of the breast. Radiol Clin North Am (2003) 0.82
Three-dimensional helical CT of the breast: accuracy for measuring extent of breast cancer candidates for breast conserving surgery. Breast Cancer Res Treat (2001) 0.82
Digital mammography. Radiographics (1998) 0.82
Breast cancer recurrence after mastectomy: diagnosis with mammography and US. Radiology (1993) 0.81
Highlights from the history of mammography. Radiographics (1990) 0.81
Correlation between quantified breast densities from digital mammography and 18F-FDG PET uptake. Breast J (2009) 0.80
Integration of imaging in the management of breast cancer. J Clin Oncol (2005) 0.80
Prototype coil for magnetic resonance imaging of the female breast. Work in progress. Radiology (1985) 0.79
Comparison between high-resolution helical CT and pathology in breast examination. Acta Radiol (2002) 0.78
Computerized reconstructive tomography applied to breast pathology. AJR Am J Roentgenol (1976) 0.77
Future applications and innovations of clinical breast magnetic resonance imaging. Top Magn Reson Imaging (2008) 0.77
Recurrent disease after breast preserving therapy (BPT) and radiation therapy for breast cancer--diagnostic yield of palpation, mammography and ultrasonography. Ultraschall Med (2007) 0.77
Diagnostic value of palpation and ultrasonography for diagnosing breast cancer recurrence after mastectomy--a comparison. Ultraschall Med (2009) 0.76
Contrast media: procedural capacities and potential risks. Rev Cardiovasc Med (2008) 0.76
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med (2005) 7.61
Expenditures and health status among adults with back and neck problems. JAMA (2008) 6.11
A randomized trial of epidural glucocorticoid injections for spinal stenosis. N Engl J Med (2014) 5.01
The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med (2015) 4.75
Rapid magnetic resonance imaging vs radiographs for patients with low back pain: a randomized controlled trial. JAMA (2003) 4.52
Global epidemiology of hepatitis B virus. J Clin Gastroenterol (2004) 4.48
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis. Value Health (2007) 3.93
Examining the value and quality of health economic analyses: implications of utilizing the QHES. J Manag Care Pharm (2003) 3.34
The Burden of Obstructive Lung Disease Initiative (BOLD): rationale and design. COPD (2005) 2.66
Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care (2008) 2.64
The coming epidemic of obesity in elderly Americans. J Am Geriatr Soc (2004) 2.55
Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med (2013) 2.54
Cardiovascular events associated with ipratropium bromide in COPD. Chest (2009) 2.36
Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care (2003) 2.33
Hormone therapy prescribing patterns in the United States. Obstet Gynecol (2004) 2.29
Trends and geographic variation of opiate medication use in state Medicaid fee-for-service programs, 1996 to 2002. Med Care (2006) 2.28
Can we reliably benchmark health technology assessment organizations? Int J Technol Assess Health Care (2012) 2.27
Cost-effectiveness and population outcomes of general population screening for hepatitis C. Clin Infect Dis (2012) 2.19
Health care costs among renal cancer patients using pazopanib and sunitinib. J Manag Care Spec Pharm (2015) 2.15
The Academy of Managed Care Pharmacy Format for Formulary Submissions: an evolving standard--a Foundation for Managed Care Pharmacy Task Force report. Value Health (2003) 2.07
Methods to assess intended effects of drug treatment in observational studies are reviewed. J Clin Epidemiol (2004) 2.03
Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers. Appl Health Econ Health Policy (2014) 2.02
Effectiveness of screening examinations to detect unrecognized exercise-induced bronchoconstriction. J Pediatr (2002) 1.96
The impact of computerized provider order entry on medication errors in a multispecialty group practice. J Am Med Inform Assoc (2010) 1.85
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers. Health Policy (2010) 1.83
Cost effectiveness of lung-volume-reduction surgery for patients with severe emphysema. N Engl J Med (2003) 1.79
Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations? Int J Technol Assess Health Care (2010) 1.70
The impact of e-prescribing on prescriber and staff time in ambulatory care clinics: a time motion study. J Am Med Inform Assoc (2007) 1.64
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decision. Ann Surg (2011) 1.63
Medicaid prior authorization and controlled-release oxycodone. Med Care (2008) 1.61
Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc (Wash) (2002) 1.59
Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol (2003) 1.57
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol (2007) 1.50
Cost-effectiveness of early intervention with once-daily budesonide in children with mild persistent asthma: results from the START study. Pediatr Allergy Immunol (2006) 1.45
The timing of elective colectomy in diverticulitis: a decision analysis. J Am Coll Surg (2004) 1.45
Comparison of guideline-based control definitions and associations with outcomes in severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2008) 1.44
The utility of the Health Plan Employer Data and Information Set (HEDIS) asthma measure to predict asthma-related outcomes. Ann Allergy Asthma Immunol (2004) 1.44
Patients' experience and outcomes after laparoscopic adjustable gastric banding in Washington state. Surg Obes Relat Dis (2012) 1.42
The impact of methodological approach on cost findings in comparison of epoetin alfa with darbepoetin alfa. Ann Pharmacother (2009) 1.42
Response to Wolf [corrected] and Marks. J Allergy Clin Immunol (2005) 1.39
Is 20% of a loaf enough? Cancer (2013) 1.38
A multisite randomized trial of the effects of physician education and organizational change in chronic-asthma care: health outcomes of the Pediatric Asthma Care Patient Outcomes Research Team II Study. Arch Pediatr Adolesc Med (2004) 1.30
Quantifying losses to the donated blood supply due to donor deferral and miscollection. Transfusion (2004) 1.29
A model for incorporating patient and stakeholder voices in a learning health care network: Washington State's Comparative Effectiveness Research Translation Network. J Clin Epidemiol (2013) 1.28
Application of economic analyses in U.S. managed care formulary decisions: a private payer's experience. J Manag Care Pharm (2007) 1.27
Asthma outcomes: healthcare utilization and costs. J Allergy Clin Immunol (2012) 1.23
Review and meta-analysis of biomarkers and diagnostic imaging in Alzheimer's disease. J Alzheimers Dis (2011) 1.22
Economic costs of nonmedical use of prescription opioids. Clin J Pain (2011) 1.22
Cost-effectiveness analysis of laparoscopic gastric bypass, adjustable gastric banding, and nonoperative weight loss interventions. Surg Obes Relat Dis (2007) 1.19
Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache (2011) 1.17
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary disease. Value Health (2004) 1.17
Updated evaluation of the cost-effectiveness of lung volume reduction surgery. Chest (2007) 1.16
Colony-stimulating factor prescribing patterns in patients receiving chemotherapy for cancer. Am J Manag Care (2010) 1.15
EBM, HTA, and CER: clearing the confusion. Milbank Q (2010) 1.15
Collaborative care model to improve outcomes in major depression. Ann Pharmacother (2002) 1.12
Comparison of hospitalization rates in patients with community-acquired pneumonia treated with telithromycin for 5 or 7 days or clarithromycin for 10 days. Curr Med Res Opin (2004) 1.11
Association between antiepileptic drug switching and epilepsy-related events. Epilepsy Behav (2009) 1.10
Electronic prescribing at the point of care: a time-motion study in the primary care setting. Health Serv Res (2009) 1.06
Randomized trial of pharmacist interventions to improve depression care and outcomes in primary care. Am J Health Syst Pharm (2004) 1.05
The practicality and validity of directly elicited and SF-36 derived health state preferences in patients with low back pain. Health Econ (2002) 1.00
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 1.00
Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B. Pharmacoeconomics (2007) 1.00
Health care utilization and cost among adults with chronic rhinosinusitis enrolled in a health maintenance organization. Otolaryngol Head Neck Surg (2002) 1.00
Practice-level effects of interventions to improve asthma care in primary care settings: the Pediatric Asthma Care Patient Outcomes Research Team. Health Serv Res (2005) 1.00
Characterization of prescribing errors in an internal medicine clinic. Am J Health Syst Pharm (2007) 0.97
An evaluation of the potential cost-effectiveness of non-invasive testing strategies in the diagnosis of significant liver fibrosis. J Gastroenterol Hepatol (2009) 0.95
Quality of life in adolescents with mild asthma. Pediatr Pulmonol (2003) 0.95
Trends in cost and outcomes among adult and pediatric patients with asthma: 2000-2009. Ann Allergy Asthma Immunol (2013) 0.95
Utilization and costs of health care after geriatric traumatic brain injury. J Neurotrauma (2012) 0.94
Community blood supply model: development of a new model to assess the safety, sufficiency, and cost of the blood supply. Med Decis Making (2005) 0.94
Study protocol: the Back Pain Outcomes using Longitudinal Data (BOLD) registry. BMC Musculoskelet Disord (2012) 0.94
Advanced diagnostic breast cancer imaging: variation and patterns of care in Washington state. J Oncol Pract (2013) 0.93
Assessing attitudes toward electronic prescribing adoption in primary care: a survey of prescribers and staff. Inform Prim Care (2010) 0.93
Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal in Russian cities. J Med Econ (2013) 0.93
Cost analysis of interventions for antimuscarinic refractory patients with overactive bladder. Urology (2010) 0.93
Cost of chronic hepatitis B infection in the United States. J Clin Gastroenterol (2004) 0.93
Associations of patient outcomes with level of asthma control. Ann Allergy Asthma Immunol (2012) 0.93
Health technology assessment for resource allocation decisions: are key principles relevant for Latin America? Int J Technol Assess Health Care (2010) 0.92
Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach. Pharmacotherapy (2011) 0.92
Comparison of directly elicited preferences to preferences derived from the SF-36 in adults with asthma. Med Decis Making (2003) 0.92
Clinical use of medical devices in the 'Bermuda Triangle'. Health Aff (Millwood) (2004) 0.92
The cost-effectiveness of onabotulinumtoxinA for the prophylaxis of headache in adults with chronic migraine in the UK. J Med Econ (2013) 0.92
Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: a review of published evidence. BMC Urol (2009) 0.91
Toward evidence-based assessment for coverage and reimbursement of laboratory-based diagnostic and genetic tests. Am J Manag Care (2006) 0.90
Cost-effectiveness of primary versus secondary prophylaxis with pegfilgrastim in women with early-stage breast cancer receiving chemotherapy. Value Health (2008) 0.89
A framework for assessing the value of diagnostic imaging in the era of comparative effectiveness research. Radiology (2011) 0.89
States' control of prescription drug spending: a heterogeneous approach. Health Aff (Millwood) (2005) 0.89
Cost-effectiveness of peginterferon alpha-2a compared with lamivudine treatment in patients with HBe-antigen-positive chronic hepatitis B in the United Kingdom. Eur J Gastroenterol Hepatol (2007) 0.89
Epidural Corticosteroid Injections for Radiculopathy and Spinal Stenosis: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 0.88
Private sector risk-sharing agreements in the United States: trends, barriers, and prospects. Am J Manag Care (2015) 0.88
Study protocol- Lumbar Epidural steroid injections for Spinal Stenosis (LESS): a double-blind randomized controlled trial of epidural steroid injections for lumbar spinal stenosis among older adults. BMC Musculoskelet Disord (2012) 0.88
Examining the BMI-mortality relationship using fractional polynomials. BMC Med Res Methodol (2011) 0.87